| 
	    | 
    
 
      
         | 
       
      
        | 
		
     |  
      
      
         | 
       
      
        
            
              
			  		   
		  		  We are a professional manufacturer of pharmaceutical raw materials and intermediate of sartan series. 
Mainly products: OTBN,BR-OTBN,BBTT,Valsartan,Olmesartan,Losartan,Candesartan,Telmisartan,Irbesartan,BCFI,DMDO-CL,Trityl Olmesartan,Trityl Valsartan,ect. | 
             
          | 
       
      
         | 
       
      
        
            
              | OTBN, BBTT, TTBB, Valsartan, Olmesartan, Candesartan, Telmisartan, Losartan, DMDO-CL, BCFI, Irbesartan, BR-OTBN, 3,5-Dimethoxy benzaldehyde, Resveratrol, Trityl Olmesartan, Trityl Valsartan, L-Valine methyl ester hydrochloride, Pterostilbene, TTMB | 
             
           
            
  | 
       
      
      
        
            
               | 
             
            
              
                  
                    
                      | Company :  | 
                      XinZhongRong Pharmaceutical Industry co.,ltd. | 
                     
                    
                      | Email:  | 
                       Contact us   | 
                     
                    
                      | URL:  | 
                      				  ********
				 				  | 
                     
                    
                      | Phone:  | 
                      
                                            *********
                                             | 
                     
                    
                      | Fax :  | 
                      
                                            *********
                      					   | 
                     
					                     
                      | Country :  | 
                      China | 
                     
                    
                      | Address :  | 
                      
                                            *********
                                             | 
                     
                  
                 
                  
  | 
             
          | 
       
      
        | 
		   | 
       
      
      
    
     
	 |